Cargando…

Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance

In high-risk individuals participating in a pancreatic cancer surveillance program, worrisome features warrant for intensified surveillance or, occasionally, surgery. Our objectives were to determine the patient-reported burden of intensified surveillance and/or surgery, and to assess post-operative...

Descripción completa

Detalles Bibliográficos
Autores principales: Overbeek, Kasper A., Cahen, Djuna L., Kamps, Anne, Konings, Ingrid C. A. W., Harinck, Femme, Kuenen, Marianne A., Koerkamp, Bas Groot, Besselink, Marc G., van Eijck, Casper H., Wagner, Anja, Ausems, Margreet G. E., van der Vlugt, Manon, Fockens, Paul, Vleggaar, Frank P., Poley, Jan-Werner, van Hooft, Jeanin E., Bleiker, Eveline M. A., Bruno, Marco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242488/
https://www.ncbi.nlm.nih.gov/pubmed/32193697
http://dx.doi.org/10.1007/s10689-020-00171-8
_version_ 1783537252531437568
author Overbeek, Kasper A.
Cahen, Djuna L.
Kamps, Anne
Konings, Ingrid C. A. W.
Harinck, Femme
Kuenen, Marianne A.
Koerkamp, Bas Groot
Besselink, Marc G.
van Eijck, Casper H.
Wagner, Anja
Ausems, Margreet G. E.
van der Vlugt, Manon
Fockens, Paul
Vleggaar, Frank P.
Poley, Jan-Werner
van Hooft, Jeanin E.
Bleiker, Eveline M. A.
Bruno, Marco J.
author_facet Overbeek, Kasper A.
Cahen, Djuna L.
Kamps, Anne
Konings, Ingrid C. A. W.
Harinck, Femme
Kuenen, Marianne A.
Koerkamp, Bas Groot
Besselink, Marc G.
van Eijck, Casper H.
Wagner, Anja
Ausems, Margreet G. E.
van der Vlugt, Manon
Fockens, Paul
Vleggaar, Frank P.
Poley, Jan-Werner
van Hooft, Jeanin E.
Bleiker, Eveline M. A.
Bruno, Marco J.
author_sort Overbeek, Kasper A.
collection PubMed
description In high-risk individuals participating in a pancreatic cancer surveillance program, worrisome features warrant for intensified surveillance or, occasionally, surgery. Our objectives were to determine the patient-reported burden of intensified surveillance and/or surgery, and to assess post-operative quality of life and opinion of surgery. Participants in our pancreatic cancer surveillance program completed questionnaires including the Cancer Worry Scale (CWS) and the Hospital Anxiety and Depression Scale (HADS). For individuals who underwent intensified surveillance, questionnaires before, during, and ≥ 3 weeks after were analyzed. In addition, subjects who underwent intensified surveillance in the past 3 years or underwent surgery at any time, were invited for an interview, that included the Short-Form 12 (SF-12). A total of 31 high-risk individuals were studied. During the intensified surveillance period, median CWS scores were higher (14, IQR 7), as compared to before (12, IQR 9, P = 0.007) and after (11, IQR 7, P = 0.014), but eventually returned back to baseline (P = 0.823). Median HADS scores were low: 5 (IQR 6) for anxiety and 3 (IQR 5) for depression, and they were unaffected by the intensified surveillance period. Of the 10 operated patients, 1 (10%) developed diabetes and 7 (70%) pancreatic exocrine insufficiency. The interviews yielded median quality-of-life scores comparable to the general population. Also, after surgery, patients’ attitudes towards surveillance were unchanged (5/10, 50%) or became more positive (4/10, 40%). Although patients were aware of the (sometimes benign) pathological outcome, when asked if surgery had been justified, only 20% (2/10) disagreed, and all would again have chosen to undergo surgery. In conclusion, in individuals at high risk for pancreatic cancer, intensified surveillance temporarily increased cancer worries, without affecting general anxiety or depression. Although pancreatic surgery led to substantial co-morbidity, quality of life was similar to the general population, and surgery did not negatively affect the attitude towards surveillance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10689-020-00171-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7242488
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-72424882020-06-03 Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance Overbeek, Kasper A. Cahen, Djuna L. Kamps, Anne Konings, Ingrid C. A. W. Harinck, Femme Kuenen, Marianne A. Koerkamp, Bas Groot Besselink, Marc G. van Eijck, Casper H. Wagner, Anja Ausems, Margreet G. E. van der Vlugt, Manon Fockens, Paul Vleggaar, Frank P. Poley, Jan-Werner van Hooft, Jeanin E. Bleiker, Eveline M. A. Bruno, Marco J. Fam Cancer Original Article In high-risk individuals participating in a pancreatic cancer surveillance program, worrisome features warrant for intensified surveillance or, occasionally, surgery. Our objectives were to determine the patient-reported burden of intensified surveillance and/or surgery, and to assess post-operative quality of life and opinion of surgery. Participants in our pancreatic cancer surveillance program completed questionnaires including the Cancer Worry Scale (CWS) and the Hospital Anxiety and Depression Scale (HADS). For individuals who underwent intensified surveillance, questionnaires before, during, and ≥ 3 weeks after were analyzed. In addition, subjects who underwent intensified surveillance in the past 3 years or underwent surgery at any time, were invited for an interview, that included the Short-Form 12 (SF-12). A total of 31 high-risk individuals were studied. During the intensified surveillance period, median CWS scores were higher (14, IQR 7), as compared to before (12, IQR 9, P = 0.007) and after (11, IQR 7, P = 0.014), but eventually returned back to baseline (P = 0.823). Median HADS scores were low: 5 (IQR 6) for anxiety and 3 (IQR 5) for depression, and they were unaffected by the intensified surveillance period. Of the 10 operated patients, 1 (10%) developed diabetes and 7 (70%) pancreatic exocrine insufficiency. The interviews yielded median quality-of-life scores comparable to the general population. Also, after surgery, patients’ attitudes towards surveillance were unchanged (5/10, 50%) or became more positive (4/10, 40%). Although patients were aware of the (sometimes benign) pathological outcome, when asked if surgery had been justified, only 20% (2/10) disagreed, and all would again have chosen to undergo surgery. In conclusion, in individuals at high risk for pancreatic cancer, intensified surveillance temporarily increased cancer worries, without affecting general anxiety or depression. Although pancreatic surgery led to substantial co-morbidity, quality of life was similar to the general population, and surgery did not negatively affect the attitude towards surveillance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10689-020-00171-8) contains supplementary material, which is available to authorized users. Springer Netherlands 2020-03-19 2020 /pmc/articles/PMC7242488/ /pubmed/32193697 http://dx.doi.org/10.1007/s10689-020-00171-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Overbeek, Kasper A.
Cahen, Djuna L.
Kamps, Anne
Konings, Ingrid C. A. W.
Harinck, Femme
Kuenen, Marianne A.
Koerkamp, Bas Groot
Besselink, Marc G.
van Eijck, Casper H.
Wagner, Anja
Ausems, Margreet G. E.
van der Vlugt, Manon
Fockens, Paul
Vleggaar, Frank P.
Poley, Jan-Werner
van Hooft, Jeanin E.
Bleiker, Eveline M. A.
Bruno, Marco J.
Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance
title Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance
title_full Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance
title_fullStr Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance
title_full_unstemmed Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance
title_short Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance
title_sort patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242488/
https://www.ncbi.nlm.nih.gov/pubmed/32193697
http://dx.doi.org/10.1007/s10689-020-00171-8
work_keys_str_mv AT overbeekkaspera patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT cahendjunal patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT kampsanne patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT koningsingridcaw patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT harinckfemme patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT kuenenmariannea patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT koerkampbasgroot patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT besselinkmarcg patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT vaneijckcasperh patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT wagneranja patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT ausemsmargreetge patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT vandervlugtmanon patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT fockenspaul patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT vleggaarfrankp patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT poleyjanwerner patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT vanhooftjeanine patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT bleikerevelinema patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT brunomarcoj patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance
AT patientreportedburdenofintensifiedsurveillanceandsurgeryinhighriskindividualsunderpancreaticcancersurveillance